标题
The therapy of idiopathic pulmonary fibrosis: what is next?
作者
关键词
-
出版物
European Respiratory Review
Volume 28, Issue 153, Pages 190021
出版商
European Respiratory Society (ERS)
发表日期
2019-09-04
DOI
10.1183/16000617.0021-2019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lung transplantation for idiopathic pulmonary fibrosis
- (2019) Peter M George et al. Lancet Respiratory Medicine
- New Developments in Imaging Idiopathic Pulmonary Fibrosis With Hyperpolarized Xenon Magnetic Resonance Imaging
- (2019) Joseph G. Mammarappallil et al. JOURNAL OF THORACIC IMAGING
- A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
- (2019) Pauline T. Lukey et al. EUROPEAN RESPIRATORY JOURNAL
- Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality
- (2019) Benjamin Loeh et al. CHEST
- Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
- (2019) David N O'Dwyer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis
- (2019) Michael Kreuter et al. CHEST
- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis: The Future of Quantitative Analysis
- (2018) Xiaoping Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis
- (2018) Joseph M. Parker et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated CT Analysis
- (2018) Joseph Jacob et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
- (2018) Li Cheng et al. CLINICAL REHABILITATION
- Imaging biomarkers and staging in IPF
- (2018) Simon L.F. Walsh CURRENT OPINION IN PULMONARY MEDICINE
- Safety of Nintedanib Added to Pirfenidone Treatment for Idiopathic Pulmonary Fibrosis
- (2018) Kevin R. Flaherty et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pulmonary Rehabilitation in Patients With Advanced Idiopathic Pulmonary Fibrosis Referred for Lung Transplantation
- (2018) Fabrício Farias da Fontoura et al. Journal of Cardiopulmonary Rehabilitation and Prevention
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-proSP-B: A Possible Biomarker for Pulmonary Diseases?
- (2018) Nicolas Kahn et al. RESPIRATION
- Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study – Rationale and study design
- (2018) Jürgen Behr et al. RESPIRATORY MEDICINE
- The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial
- (2018) Matthew Hammond et al. Trials
- White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients
- (2018) Oriana Salamo et al. Scientific Reports
- Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study
- (2018) Sang Hoon Lee et al. Scientific Reports
- Effect of pirfenidone on wound healing in lung transplant patients
- (2018) Amber Mortensen et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials
- (2018) Margaret Neighbors et al. Lancet Respiratory Medicine
- Gazing into the crystal ball: can treatment response be predicted in IPF?
- (2018) Michael Kreuter et al. Lancet Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
- (2018) Martin Kolb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial
- (2018) Ganesh Raghu et al. Lancet Respiratory Medicine
- Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
- (2018) Dina Visca et al. Lancet Respiratory Medicine
- Idiopathic Pulmonary Fibrosis (IPF): An Overview
- (2018) Shaney Barratt et al. Journal of Clinical Medicine
- Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
- (2018) Nasreen Khalil et al. EUROPEAN RESPIRATORY JOURNAL
- The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicenter observational study
- (2018) Sebastiano Emanuele Torrisi et al. EUROPEAN RESPIRATORY JOURNAL
- No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone
- (2018) Luca Richeldi et al. EUROPEAN RESPIRATORY JOURNAL
- Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
- (2018) Kevin K. Brown et al. RESPIRATORY MEDICINE
- Pulmonary Rehabilitation in patients with Interstitial Lung Disease: The effects of a 12-week programme
- (2018) Anabel Sciriha et al. RESPIRATORY MEDICINE
- Patient outcomes from time of listing for lung transplantation in the UK: are there disease-specific differences?
- (2018) Antonios Kourliouros et al. THORAX
- Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years
- (2017) Ganesh Raghu EUROPEAN RESPIRATORY JOURNAL
- Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
- (2017) Mirjam J.G. van Manen et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up
- (2017) Stephen M. Humphries et al. RADIOLOGY
- Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
- (2017) Michael Kreuter et al. RESPIRATION
- Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
- (2017) Kimiyuki Ikeda et al. RESPIRATORY MEDICINE
- Current approaches to the management of idiopathic pulmonary fibrosis
- (2017) Ganesh Raghu et al. RESPIRATORY MEDICINE
- Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
- (2017) Roberto Tonelli et al. BMC Pulmonary Medicine
- Palliative care in interstitial lung disease: living well
- (2017) Michael Kreuter et al. Lancet Respiratory Medicine
- Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
- (2017) Jose D Herazo-Maya et al. Lancet Respiratory Medicine
- A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
- (2017) Surinder S Birring et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
- (2017) Christopher S King et al. Lancet Respiratory Medicine
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
- (2017) Ganesh Raghu et al. Lancet Respiratory Medicine
- The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease
- (2017) Anna Spathis et al. npj Primary Care Respiratory Medicine
- Optimizing quality of life in patients with idiopathic pulmonary fibrosis
- (2017) Mirjam J. G. van Manen et al. Therapeutic Advances in Respiratory Disease
- Outcome of Patients with Interstitial Lung Disease Treated with Extracorporeal Membrane Oxygenation for Acute Respiratory Failure
- (2016) Franziska C. Trudzinski et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
- (2016) Harold R. Collard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
- (2016) Michael Kreuter et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
- (2016) Carlo Albera et al. EUROPEAN RESPIRATORY JOURNAL
- First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
- (2016) Wim A. Wuyts et al. LUNG
- PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition
- (2016) Xiao-Ling Zhang et al. Molecular Medicine Reports
- Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
- (2016) Michael Kreuter et al. THORAX
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
- (2016) Isabelle Delanote et al. BMC Pulmonary Medicine
- Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis
- (2016) Chang Min Lee et al. Journal of Neurogastroenterology and Motility
- Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jürgen Behr et al. Lancet Respiratory Medicine
- Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
- (2016) Michael Kreuter et al. Lancet Respiratory Medicine
- Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
- (2016) Michael Kreuter et al. PLoS One
- TOLLIP,MUC5B, and the Response toN-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
- (2015) Justin M. Oldham et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
- (2015) Sara Tomassetti et al. CHEST
- αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease
- (2015) Gauri Saini et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
- (2015) Paul W. Noble et al. EUROPEAN RESPIRATORY JOURNAL
- Global burden of CVD: focus on secondary prevention of cardiovascular disease
- (2015) Sameer Bansilal et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis
- (2015) SAADA DIAB et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Single- vs Double-Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis Since the Implementation of Lung Allocation Based on Medical Need
- (2015) Justin M. Schaffer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease
- (2015) Vikas K. Singh et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
- (2015) David Weill et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease
- (2015) Signe Vedel-Krogh et al. PLoS One
- Symptom-based management of the idiopathic interstitial pneumonia
- (2015) Brian T. Garibaldi et al. RESPIROLOGY
- Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers
- (2015) Nathan Hambly et al. RESPIROLOGY
- Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
- (2015) Sabrina Bajwah et al. THORAX
- Be honest and help me prepare for the future
- (2015) Anne E Holland et al. Chronic Respiratory Disease
- Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
- (2015) R Gisli Jenkins et al. Lancet Respiratory Medicine
- Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
- (2015) Michael Donahoe et al. PLoS One
- Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
- (2014) Ulrich Costabel et al. ADVANCES IN THERAPY
- C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
- (2014) Louis J. Vuga et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Human lysyl oxidase-like 2
- (2014) Hee-Jung Moon et al. BIOORGANIC CHEMISTRY
- Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis
- (2014) Annette Duck et al. JOURNAL OF ADVANCED NURSING
- Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias
- (2014) Nicoline M. Korthagen et al. LUNG
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
- (2014) Alexandra Zanin-Zhorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How does comorbidity influence survival in idiopathic pulmonary fibrosis?
- (2014) Charlotte Hyldgaard et al. RESPIRATORY MEDICINE
- Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis
- (2014) Sydney B Montesi et al. BMC Pulmonary Medicine
- Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation
- (2014) Bridget D Stuart et al. Lancet Respiratory Medicine
- The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
- (2013) David N. O’Dwyer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
- (2013) Maureen R. Horton et al. ANNALS OF INTERNAL MEDICINE
- Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
- (2013) J. W. Chien et al. EUROPEAN RESPIRATORY JOURNAL
- CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis
- (2013) LIN ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients
- (2013) J. Xue et al. JOURNAL OF IMMUNOLOGY
- Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
- (2013) M.R. Dillingh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study
- (2013) Christopher J. Ryerson et al. RESPIRATORY MEDICINE
- Make Yourself at Home: Viral Hijacking of the PI3K/Akt Signaling Pathway
- (2013) Nora Diehl et al. Viruses-Basel
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- Extracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
- (2012) Thomas Fuehner et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses
- (2012) Rehan A. Kahloon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Lung transplantation in patients 70 years old or older: Have outcomes changed after implementation of the lung allocation score?
- (2012) Arman Kilic et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis
- (2012) Jeffrey J. Swigris et al. RESPIRATORY MEDICINE
- Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels
- (2012) Yasushi Horimasu et al. RESPIRATORY MEDICINE
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- Peripheral blood biomarkers in idiopathic pulmonary fibrosis
- (2012) Rekha Vij et al. Translational Research
- The Fate of Patients on the Waiting List for Lung Transplantation in Korea
- (2012) H.C. Paik et al. TRANSPLANTATION PROCEEDINGS
- International collaboration: a retrospective study examining the survival of Irish citizens following lung transplantation in both the UK and Ireland
- (2012) Huzaifa I Adamali et al. BMJ Open
- Burden of illness in idiopathic pulmonary fibrosis
- (2012) Harold R. Collard et al. JOURNAL OF MEDICAL ECONOMICS
- Delayed Access and Survival in Idiopathic Pulmonary Fibrosis
- (2011) Daniela J. Lamas et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
- (2011) Thomas J. Richards et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease
- (2011) Galina S. Bogatkevich et al. ARTHRITIS AND RHEUMATISM
- Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
- (2011) Masato Kono et al. CLINICA CHIMICA ACTA
- Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias
- (2011) Nobuhiko Nagata et al. Diagnostic Pathology
- Differential expression of monocyte/macrophage- selective markers in human idiopathic pulmonary fibrosis
- (2011) Bela Desai et al. EXPERIMENTAL LUNG RESEARCH
- Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients
- (2011) Matthias Briel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis
- (2011) Max A. Seibold et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice
- (2011) XIHUA WANG et al. RESPIROLOGY
- Cough predicts prognosis in idiopathic pulmonary fibrosis
- (2011) CHRISTOPHER J. RYERSON et al. RESPIROLOGY
- Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
- (2010) M. Okamoto et al. EUROPEAN RESPIRATORY JOURNAL
- Significance of Serum Vascular Endothelial Growth Factor Level in Patients with Idiopathic Pulmonary Fibrosis
- (2010) Masaru Ando et al. LUNG
- CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis
- (2010) Syed R. Gilani et al. PLoS One
- Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages
- (2010) Lynne A. Murray et al. PLoS One
- Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
- (2010) Steven D. Nathan et al. RESPIRATORY MEDICINE
- Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis
- (2010) Nicoline M. Korthagen et al. RESPIRATORY MEDICINE
- Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
- (2009) Antje Prasse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
- (2009) Antje Moeller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
- (2009) Kazuhisa Konishi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
- (2009) Galina S. Bogatkevich et al. ARTHRITIS AND RHEUMATISM
- Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
- (2009) Brent W. Kinder et al. CHEST
- Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis
- (2009) T. Izumo et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
- (2009) Chris J. Scotton et al. JOURNAL OF CLINICAL INVESTIGATION
- Two pathways for lysophosphatidic acid production
- (2008) J AOKI BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Protein Kinase Inhibitors in the Treatment of Pulmonary Fibrosis
- (2008) Sylvie Garneau-Tsodikova et al. CURRENT MEDICINAL CHEMISTRY
- Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis
- (2008) Jin Woo Song et al. RESPIRATORY MEDICINE
- Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis
- (2008) M R Horton et al. THORAX
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started